MeVis Medical Solutions AI Stock Analysis
Want to see DE:M3V full AI Analyst Report?
MeVis Medical Solutions (M3V) AI Stock Analysis
MeVis Medical Solutions
(XETRA:M3V)
Strong financial position with no debt and good profitability drives the score, offset by revenue declines and mild bearish technicals. Reasonable valuation adds support, but growth consistency is a key risk.
MeVis Medical Solutions (M3V) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 37.13M
- Dividend Yield
- 4.66%
- Average Volume (3M)
- 228
- Price to Earnings (P/E)
- 26.8
- Beta (1Y)
- 0.18
- Revenue Growth
- -6.92%
- EPS Growth
- -67.82%
- Country
- Germany
- Employees
- 127
- Sector
- General
- Sector Strength
- 55
- Industry
- Software - Application
MeVis Medical Solutions Business Overview & Revenue Model
Company Description
MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides...
MeVis Medical Solutions Financial Statement Overview
Summary
MeVis Medical Solutions exhibits solid financial health with a debt-free balance sheet and consistent cash flow, though revenue declines and fluctuating margins temper the outlook. Averaging income statement (65), balance sheet (85), and cash flow (70) scores reflects balanced strengths and growth challenges.
Income Statement
65PositiveBalance Sheet
85Very PositiveCash Flow
70Positive| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.48M | 16.06M | 16.97M | 17.34M | 18.76M | 16.21M |
| Gross Profit | 3.13M | 15.69M | 16.48M | 7.00M | 18.02M | 15.78M |
| EBITDA | 791.01K | 3.43M | 4.82M | 5.17M | 7.97M | 4.77M |
| Net Income | 1.38M | 3.17M | 4.56M | 4.92M | 7.79M | 4.55M |
Balance Sheet | ||||||
| Total Assets | 23.16M | 25.89M | 26.48M | 28.05M | 31.20M | 27.53M |
| Cash, Cash Equivalents and Short-Term Investments | 3.65M | 6.52M | 6.53M | 7.74M | 9.32M | 7.62M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 5.34M | 8.06M | 8.66M | 10.23M | 13.38M | 9.71M |
| Stockholders Equity | 17.83M | 17.83M | 17.83M | 17.83M | 17.83M | 17.83M |
Cash Flow | ||||||
| Free Cash Flow | 0 | 3.74M | 2.84M | 5.77M | 4.72M | 9.08M |
| Operating Cash Flow | 0 | 3.88M | 3.15M | 5.85M | 4.86M | 9.13M |
| Investing Cash Flow | 0 | 945.46K | 906.80K | 989.98K | 58.66K | 111.63K |
| Financing Cash Flow | 0 | -4.56M | -4.92M | -7.79M | -4.55M | -5.70M |
MeVis Medical Solutions Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:M3V, the sentiment is Negative. The current price of 20.40 is above the 20-day moving average (MA) of 20.27, below the 50-day MA of 21.68, and below the 200-day MA of 23.17, indicating a neutral trend. The MACD of -0.45 indicates Negative momentum. The RSI at 45.38 is Neutral, neither overbought nor oversold. The STOCH value of 85.30 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:M3V.
MeVis Medical Solutions Peers Comparison
Overall Rating
DE:EUZ80Outperform
DE:SHL77Outperform
DE:DRW870Outperform
DE:M3V68Neutral
DE:SBS54Neutral
DE:COP53Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 80Outperform | EUR 930.47M | 17.09 | 20.26% | 1.48% | 4.05% | 36.66% | |
| 77Outperform | EUR 48.31B | 21.87 | 11.72% | 2.31% | 1.09% | 3.52% | |
| 70Outperform | EUR 1.81B | 12.35 | 10.20% | 2.66% | 5.06% | 40.18% | |
| 68Neutral | EUR 37.13M | 26.84 | 7.77% | 4.66% | -6.92% | -67.82% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 54Neutral | EUR 328.82M | -7.75 | -18.69% | 2.22% | ― | ― | |
| 53Neutral | EUR 1.47B | 43.42 | 4.19% | 1.78% | ― | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:M3V | MeVis Medical Solutions | 20.40 | -3.50 | -14.64% | |
| DE:COP | CompuGroup Medical | 27.85 | 4.57 | 19.63% | |
| DE:DRW8 | Draegerwerk AG & Co. KGaA (0MT8) | 83.20 | 22.90 | 37.97% | |
| DE:EUZ | Eckert & Ziegler Strahlen und Medizintechnik | 14.87 | -0.58 | -3.74% | |
| DE:SBS | STRATEC Biomedical | 27.05 | 7.57 | 38.89% | |
| DE:SHL | Siemens Healthineers | 43.30 | 2.90 | 7.18% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 04, 2026
